Skip to content

Current Controversies in the Biological Sciences Case Studies of Policy Challenges from New Technologies

Best in textbook rentals since 2012!

ISBN-10: 0262572397

ISBN-13: 9780262572392

Edition: 2007

Authors: Karen F. Greif, Jon F. Merz

List price: $35.00
Blue ribbon 30 day, 100% satisfaction guarantee!
what's this?
Rush Rewards U
Members Receive:
Carrot Coin icon
XP icon
You have reached 400 XP and carrot coins. That is the daily max!

Description:

In recent years, advances in biological science and technology have outpaced policymakersrsquo; attempts to deal with them. Current Controversies in the Biological Sciencesexamines the ways in which the federal government uses scientific information in reaching policy decisions, providing case studies of the interactions between science and government on different biomedical, biological, and environmental issues. These case studies document a broad range of complex issues in science policy--from the Human Genome Project to tobacco regulation--and provide an accessible overview of both the science behind the issues and the policy-making process. The cases illustrate the different ways in…    
Customers also bought

Book details

List price: $35.00
Copyright year: 2007
Publisher: MIT Press
Publication date: 2/23/2007
Binding: Paperback
Pages: 400
Size: 7.50" wide x 8.25" long x 1.25" tall
Weight: 1.386
Language: English

Karen F. Greif is Professor of Biology at Bryn Mawr College.

Jon F. Merz is Associate Professor in the Department of Medical Ethics at the University ofPennsylvania School of Medicine.

Series Foreword
Preface
Acknowledgments
An Uneasy Balance: Science Advising and the Politicization of Science
Big Science: The Human Genome Project and the Public Funding of Science
Funding Biomedical Research: Peer Review versus Pork Barrel
Choosing Research Directions: Advocacy, the "Disease-of-the-Month," and Congressional Oversight
Who Owns the Genome? The Patenting of Human Genes
Who Owns Life? Mr. Moore's Spleen
The Canavan Disease Patent Case
Manufacturing Children: Assisted Reproductive Technologies and Self-Regulation by Scientists and Clinicians
Brave New World Revisited: Human Cloning and Stem Cells
The Asilomar Conference on Recombinant DNA: A Model for Self-Regulation?
Protecting the Public: The FDA and New AIDS Drugs
Seminal Events: The Evolution of Regulations for Research
Placebo Controls in Clinical Research
Cosmetic Science: Breast Implants and the Courts
Setting Limits on Expert Testimony: Bendectin and Birth Defects
DNA Forensics in Criminal Trials: How New Science Becomes Admissible
Selling Science: New Cancer Treatments and the Media
Responsible Journalism: Are There Health Risks from Electromagnetic Fields?
Concealing Evidence: Science, Big Business, and the Tobacco Industry
The Academic-Industrial Complex and Conflict of Interest
The Darker Side of Science: Scientific Misconduct
Science in the National Interest: Bioterrorism and Civil Liberties
Emerging Diseases: SARS and Government Responses
Limiting Research in an Age of Bioterrorism
Science Misunderstood: Genetically Modified Organisms and International Trade
Mad Cow Disease, International Trade, and the Loss of Public Trust
Dangers in the Environment: Air Pollution Policy
Environmental Poisoning: Mitigating Lead Exposure
Can We Ever Be Safe? Risk and Risk Assessment
Who Lives and Who Dies? Organ Transplantation
Animals as Organ Factories: Xenotransplantation
Is There a Right to Die?
Concluding Remarks: The Challenges of Science Policy
Index